Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Acuitybio

Acuitybio?uq=hBqTzBbB
PRIVATE STATUS
1-10 EMPLOYEES
Series A LATEST DEAL TYPE
$2.45M LATEST DEAL AMOUNT
3 INVESTORS
Description

Developer of bio-compatible and biodegradable drug-eluting surgical products intended to commercialize novel polymer drug delivery technologies. The company's products are implemented with safety and efficacy in preclinical models, long-term targeted delivery of therapeutic levels of paclitaxel to areas at highest risk for harboring residual cancer cells and can be applied to additional indications besides lung cancer, enabling surgeons to administer during initial tumor removal surgery and prevent recurrence.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Surgical Devices
Primary Office
  • 321 Walnut Street
  • Suite 300
  • Newton, MA 02460
  • United States

+1 (617) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Acuitybio’s full profile, request a free trial.

Acuitybio Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Angel (individual) 13-Nov-2017 $2.45M 00.000 000.00 Completed Generating Revenue
4. Grant Completed Generating Revenue
3. Grant 01-Jul-2013 00000 Completed Generating Revenue
2. Grant 16-Sep-2011 $1.4M Completed Generating Revenue
1. Grant 01-Jan-2008 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Acuitybio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 0,000,000 00.000000 00.00 00.00 00 00.00 00.00
To view this company’s complete Cap Table, request access »

Acuitybio Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
U.S. Department of Health and Human Services Government 000 0000 000000 0
National Cancer Institute Government 000 0000 000000 0
Internal Revenue Service Government 000 0000 000000 0

Acuitybio Executive Team (6)

Name Title Board
Seat
Contact
Info
Alain Hanover Co-Founder & Board Member
John Schwartz Ph.D Co-Founder, Chairman & Chief Executive Officer
Karen English Chief Financial Officer & Board Member
Oded Biran CBO
Jesse Wolinsky Ph.D Co-Founder
You’re viewing 5 of 6 executives. Get the full list »

Acuitybio Board Members (6)

Name Representing Role Since Contact
Info
Alain Hanover Acuitybio Co-Founder & Board Member 000 0000
Eyal Ron Ph.D Self Board Member & Advisor 000 0000
Karen English Acuitybio Chief Financial Officer & Board Member 000 0000
Mark Grinstaff Ph.D Self Co-Founder & Board Member 000 0000
Peter Lui Acuitybio Board Member 000 0000

1 Former Board Member

You’re viewing 5 of 6 board members. Get the full list »